Niaprazine

This classification denotes a sedative and hypnotic with the molecular formula C20H25FN4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R2H3YN6E3L, chemically known as 3-pyridinecarboxamide, n-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)- (9ci) but generally known as niaprazine, which bears US NIH Compound Identifier 71919. European Medicines Agency schedules Niaprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09218MIG. The term NIAPRAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules niaprazine in its Anatomical Therapeutic Chemical (ATC) Classification. NIAPRAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule niaprazine under HS 29335995 and SITC 51576. As of Q4 2014, NIAPRAZINE remains the US FDA Preferred Term for this commodity. Niaprazine bears US NLM identifiers UMLS ID C0068673 and NCI Concept Code C76943. SMILES: FC1CCC(N2CCN(CC2)CCC(NC(=O)C2CCCNC2)C)CC1.